-
Feb 24, 2025 | 
femtechworld.co.uk | Sorina Mihaila
ARC, the global health innovation engine and transformation arm of Sheba Medical Center, has announced a collaboration with remote pregnancy monitoring medtech Nuvo. Their aim is to co-develop AI solutions that improve clinical decision-making and early detection of pregnancy complications. Nuvo’s remote monitoring tech enables expectant mothers to track their pregnancy from home.
-
Feb 14, 2025 | 
femtechworld.co.uk | Sorina Mihaila
The aesthetic business has ushered in a new era whereby people can get firm, younger-looking skin without resorting to drastic surgery. Though efficient, traditional facelifts are risky and sometimes require a long recovery. As technology develops, minimally invasive procedures are the preferred option for those looking for long-term skin rejuvenation. These procedures offer obvious benefits with minimal downtime for those wishing to keep a naturally young look.
-
Feb 4, 2025 | 
femtechworld.co.uk | Sorina Mihaila
Visa Foundaton has launched the CatalyseHer Programme in the UK and is aiming to provide 500 women entrepreneurs with training and fundraising support to grow their businesses and make them more attractive to investors. The programme includes training, networking and micro-grants and is aimed at early stage, women-owned businesses. It is seeking to 500 UK-based female founders to address the gender financing gap facing women entrepreneurs in the UK.
-
Jan 29, 2025 | 
femtechworld.co.uk | Sorina Mihaila
The multinational has received FDA clearance in the US for the updated version of its Voluson Expert series of ultrasound systems. The tech features AI-driven functionality and tools which it says will support faster assessments and early detection, diagnosis and intervention. Its ‘SonoLyst’ suite of AI tools is designed to simplify exams via image recognition and automated annotations and measurements.
-
Nov 1, 2024 | 
femtechworld.co.uk | Sorina Mihaila
Researchers conducted a review of over 12,000 papers and 87 articles for different AI and related software tools, investigating the impact of their use in maternity settings. A meta-analysis of 35 included studies found the odds of improved outcomes was 1.69 times higher in women cared for using CDSS, with data from over 5.2 million pregnancies in both high-income and low-and-middle-income countries.
-
Oct 21, 2024 | 
femtechworld.co.uk | Sorina Mihaila
It also suggests that the most commonly experienced perimenopause symptoms are mood changes (92 per cent), anxiety (90 per cent), bloating (90 per cent), decreased interest in sex (80 per cent), and difficulty sleeping (80 per cent). Furthermore, 44 per cent of women said their careers were impacted by perimenopause. The data is based on a survey of 700 women ages 35-52 across all 50 US states, and anonymised hormone data from 1,700 users of women’s health platform Oova.
-
Oct 7, 2024 | 
femtechworld.co.uk | Sorina Mihaila
AOA Dx was founded in 2020 with the aim of giving women access to the most innovative early detection platform in their fight against cancer. Femtech World caught up with CEO and co-founder Oriana Papin-Zoghbi for our latest Insider Insight piece. What is your morning routine? I try to wake up before my toddler to enjoy a quiet morning with a cup of coffee, but most days, she’s an early riser, and we jump straight into breakfast.
-
Oct 2, 2024 | 
femtechworld.co.uk | Sorina Mihaila
Data suggests that 53.3 per cent of commercially insured women received their recommended screening mammogram between 2022 and 2023. This is up from 47.3 per cent in the prior two-year period, an increase of nearly 13 per cent. But almost half of women are still missing out on these critical screenings. Cedar Gate Technologies’ predictive AI model has identified that approximately 52 per cent of women due for a mammogram in the coming year are unlikely to get it.
-
Oct 1, 2024 | 
femtechworld.co.uk | Sorina Mihaila
Endometriosis affects an estimated one in 10 women of reproductive age globally—approximately 190 million women. Yet, despite its prevalence, research into this condition has been grossly underfunded and underprioritised. Recent statistics suggest that only 2 percent of medical research funding is spent on pregnancy, childbirth, and female reproductive health. This is despite one in three women reporting a reproductive or gynaecological health problem.
-
Sep 23, 2024 | 
femtechworld.co.uk | Sorina Mihaila
Patients insured by Medicaid are less likely to get prenatal diagnosis of heart defects than those with private insurance, and this disparity can be partly attributed to lower rates of 20-week ultrasound in pregnant people with public insurance, according to a study led by Ann & Robert H. Lurie Children’s Hospital of Chicago in collaboration with Advocate Christ Children’s Hospital. The study was published in the journal Prenatal Diagnosis.
